Miracle Survival: Russian Doctors Remove 1.5-Kilogram Tumor from Newborn

Miracle Survival: Russian Doctors Remove 1.5-Kilogram Tumor from Newborn

Robert Howard
Robert Howard
2 Min.
An animated red kidney is displayed in detail against a white background.

Miracle Survival: Russian Doctors Remove 1.5-Kilogram Tumor from Newborn

A newborn baby in Krasnodar Krai has survived a life-threatening battle after doctors removed a 1.5-kilogram malignant tumour. The infant, weighing just 6 kilograms at the time, was diagnosed with nephroblastoma—a rare and aggressive kidney cancer. The case was later shared by the region's Health Minister, Yevgeny Filipov, on social media.

The baby was born healthy but soon developed a rapid swelling in the abdomen. Tests revealed a massive tumour, accounting for nearly a quarter of the infant's body weight. Due to the child's extremely young age, the surgery carried high risks.

Doctors at the Krasnodar Regional Children's Clinical Hospital performed the complex operation successfully. The removal of the tumour was a critical step in saving the baby's life.

Over the past decade, Russia has seen significant improvements in treating nephroblastomas, also known as Wilms tumours. Enhanced use of SIOP protocols and centralised care at specialised centres, such as the Dmitry Rogachev National Medical Research Center, has boosted survival rates. For localised cases, the five-year survival rate has risen from around 85–90% to over 95%. Advances in treatment now include risk-adapted chemotherapy, reduced-intensity regimens to lower toxicity in infants, and targeted therapies like anti-IGF2 antibodies, introduced in clinical trials since 2022. Better surgical techniques and supportive care have also reduced mortality from complications.

The successful surgery marks a critical moment in the infant's recovery. With modern medical advancements, the outlook for children diagnosed with nephroblastoma in Russia has improved significantly. The case highlights the importance of specialised care and innovative treatments in fighting rare childhood cancers.

Neueste Nachrichten